MHR
Matthew Hamilton Rosenberg’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4
| Closed | -$461 | – | 845 |
|
|
2024
Q3 | $461 | Hold |
4
| – | – | ﹤0.01% | 801 |
|
|
2024
Q2 | $560 | Hold |
4
| – | – | ﹤0.01% | 760 |
|
|
2024
Q1 | $566 | Hold |
4
| – | – | ﹤0.01% | 798 |
|
|
2023
Q4 | $527 | Hold |
4
| – | – | ﹤0.01% | 822 |
|
|
2023
Q3 | $450 | Hold |
4
| – | – | ﹤0.01% | 826 |
|
|
2023
Q2 | $377 | Hold |
4
| – | – | ﹤0.01% | 857 |
|
|
2023
Q1 | $405 | Hold |
4
| – | – | ﹤0.01% | 887 |
|
|
2022
Q4 | $478 | Buy |
+4
| New | +$478 | ﹤0.01% | 873 |
|